J&J AIDS Pill Signals $9 Billion in Sales to Ease Recall Woes

of AIDS drugs, and may generate sales of $870 million for J&J in 2015, said Larry Biegelsen, a Wells Fargo & Co. analyst in New York, in a May 20 note. Merck, based in Whitehouse Station, New Jersey, won FDA approval this month for its hepatitis C drug,...